+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Postmenopausal estrogen use and invasive versus in situ breast cancer risk



Postmenopausal estrogen use and invasive versus in situ breast cancer risk



Journal of Clinical Epidemiology 51(12): 1277-1283



To examine the effect of cancer histopathology on the relationship between estrogen-replacement therapy (ERT) use and breast cancer risk, we performed a case-control study of 109 postmenopausal women 45 years or older with in situ or invasive breast cancer matched to 545 controls. When in situ and invasive tumors were combined, the overall odds ratio (OR) describing the association between ERT use and breast cancer risk was not statistically significantly elevated (adjusted OR = 1.48, 95% confidence interval [CI] = 0.89-2.47). When the analyses were confined to women with invasive disease, risk estimates were uniformly higher (adjusted OR = 1.85, 95% CI = 1.00-3.45). In contrast, the overall estimate for the relationship between ERT use and in situ breast cancer was close to 1 (adjusted OR = 1.08, 95% CI = 0.42-2.77). The positive association between ERT use and invasive breast cancer we observed, and the lack of association in women with in situ disease, may represent a distinct biological difference or may be related to the small sample size of our study.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068717469

Download citation: RISBibTeXText

PMID: 10086820

DOI: 10.1016/s0895-4356(98)00116-4


Related references

Postmenopausal estrogen use and invasive versus in situ breast cancer risk. Journal of Clinical Epidemiology 51(12): 1277-1283, 1998

Risk factors for breast carcinoma in situ vs invasive breast cancer in a prospective study of pre- and postmenopausal women, 1996-2002. American Journal of Epidemiology 159(11, Suppl S): S104, 2004

Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Research 12(3): R35, 2010

Raloxifene: a selective estrogen receptor modulator for reducing the risk of invasive breast cancer in postmenopausal women. Women's Health 3(2): 139-153, 2007

ACP Journal Club. Estrogen plus progestin increased long-term risk for invasive breast cancer in postmenopausal women. Annals of Internal Medicine 154(4): Jc2-J11, 2011

Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women. Breast Cancer Research and Treatment 103(3): 343-348, 2007

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk. Menopause 15(4 Suppl): 804-809, 2008

Estrogen and Estrogen-Progestin Replacement Therapy and Risk of Postmenopausal Breast Cancer in Canada. Cancer Causes & Control 13(6): 583-590, 2002

Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada. Cancer Causes & Control 13(6): 583-590, 2002

An Estrogen-Related Dietary Pattern and Postmenopausal Breast Cancer Risk in a Cohort of Women with a Family History of Breast Cancer. Cancer Epidemiology Biomarkers and Prevention 27(10): 1223-1226, 2018

Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk. Clinical Cancer Research 12(17): 5242-5247, 2006

Effect of Raloxifene on the Incidence of Invasive Breast Cancer in Postmenopausal Women With Osteoporosis Categorized by Breast Cancer Risk. Breast Diseases: A Year Book Quarterly 18(2): 203-204, 2007

Postmenopausal estrogen and the risk of breast cancer. Annals of Epidemiology 4(3): 177-180, 1994

Risk factors for breast cancer death and subsequent invasive breast cancer after a primary ductal carcinoma in situ of the breast A population-based case-control study. Breast Cancer Research & Treatment 46(1): 44, 1997

Low-risk factor profile, estrogen levels, and breast cancer risk among postmenopausal women. International Journal of Cancer 124(8): 1935-1940, 2009